ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $96,000 | +113.3% | 10,600 | 0.0% | 0.01% | +160.0% |
| Q4 2017 | $45,000 | -19.6% | 10,600 | -51.6% | 0.01% | -37.5% |
| Q1 2017 | $56,000 | -12.5% | 21,884 | -13.4% | 0.01% | -11.1% |
| Q4 2016 | $64,000 | -25.6% | 25,284 | -8.9% | 0.01% | -30.8% |
| Q3 2016 | $86,000 | -11.3% | 27,743 | -8.6% | 0.01% | -18.8% |
| Q2 2016 | $97,000 | +3.2% | 30,338 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $94,000 | -23.0% | 30,338 | 0.0% | 0.02% | -27.3% |
| Q4 2015 | $122,000 | -43.0% | 30,338 | -35.1% | 0.02% | -48.8% |
| Q3 2015 | $214,000 | -17.7% | 46,728 | -6.7% | 0.04% | -10.4% |
| Q2 2015 | $260,000 | -10.0% | 50,110 | +8.7% | 0.05% | -2.0% |
| Q1 2015 | $289,000 | -10.0% | 46,090 | -9.7% | 0.05% | 0.0% |
| Q4 2014 | $321,000 | -13.9% | 51,040 | -16.8% | 0.05% | -15.5% |
| Q3 2014 | $373,000 | +39.7% | 61,326 | +51.3% | 0.06% | +34.9% |
| Q2 2014 | $267,000 | -60.9% | 40,536 | +41.5% | 0.04% | -64.2% |
| Q1 2014 | $682,000 | – | 28,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |